IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

March 11-13, 2019

Cambridge Healthtech Institute’s 4th Annual Cancer Immunotherapy: Executive Summit

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Voyager-V1: Systemic, Single-cycle, Trackable Oncolytic Virotherapy”

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com